Literature DB >> 9535125

Association study of a functional catechol-O-methyltransferase gene polymorphism in Japanese schizophrenics.

O Ohmori1, T Shinkai, H Kojima, T Terao, T Suzuki, T Mita, K Abe.   

Abstract

Catechol-O-methyltransferase (COMT) is an enzyme which inactivates catecholamine neurotransmitters by methylation, and is considered a candidate for involvement in schizophrenia. A functional COMT gene polymorphism influencing the enzyme activities, the high activity (val-108) and the low activity allele (met-108), was recently confirmed. We investigated a genetic association between schizophrenia and the COMT gene polymorphism in 150 Japanese schizophrenics and controls. We detected the low activity met-108 allele more frequently in schizophrenics than in the controls, and found that subjects sharing the met-108 allele (val/met and met/met) are significantly more common in the patients than in the controls. The results suggest that the low activity met-108 allele may be involved in susceptibility for schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9535125     DOI: 10.1016/s0304-3940(98)00100-1

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  16 in total

Review 1.  Linkage and association studies of schizophrenia.

Authors:  Peter McGuffin; Kopal Tandon; Alejandro Corsico
Journal:  Curr Psychiatry Rep       Date:  2003-06       Impact factor: 5.285

Review 2.  Genetic abnormalities of chromosome 22 and the development of psychosis.

Authors:  Nigel M Williams; Michael J Owen
Journal:  Curr Psychiatry Rep       Date:  2004-06       Impact factor: 5.285

Review 3.  Genetically mediated brain abnormalities in schizophrenia.

Authors:  Larry J Seidman; Heidi E Wencel
Journal:  Curr Psychiatry Rep       Date:  2003-06       Impact factor: 5.285

4.  Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia.

Authors:  M F Egan; T E Goldberg; B S Kolachana; J H Callicott; C M Mazzanti; R E Straub; D Goldman; D R Weinberger
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-29       Impact factor: 11.205

5.  Association of Ala72Ser polymorphism with COMT enzyme activity and the risk of schizophrenia in Koreans.

Authors:  Seong-Gene Lee; Yeonho Joo; Byungsu Kim; Seockhoon Chung; Hie-Lim Kim; Inchul Lee; Boyoul Choi; Changyoon Kim; Kyuyoung Song
Journal:  Hum Genet       Date:  2005-01-12       Impact factor: 4.132

6.  Catechol-O-methyltransferase Val 158 Met polymorphism and antisaccade eye movements in schizophrenia.

Authors:  Haraldur Magnus Haraldsson; Ulrich Ettinger; Brynja B Magnusdottir; Thordur Sigmundsson; Engilbert Sigurdsson; Andres Ingason; Hannes Petursson
Journal:  Schizophr Bull       Date:  2008-06-17       Impact factor: 9.306

7.  Personality in relation to genetic liability for schizophrenia and bipolar disorder: differential associations with the COMT Val 108/158 Met polymorphism.

Authors:  Amy L Silberschmidt; Scott R Sponheim
Journal:  Schizophr Res       Date:  2008-01-16       Impact factor: 4.939

Review 8.  The Role of a Catechol-O-Methyltransferase (COMT) Val158Met Genetic Polymorphism in Schizophrenia: A Systematic Review and Updated Meta-analysis on 32,816 Subjects.

Authors:  Thelma Beatriz González-Castro; Yazmin Hernández-Díaz; Isela Esther Juárez-Rojop; María Lilia López-Narváez; Carlos Alfonso Tovilla-Zárate; Ana Fresan
Journal:  Neuromolecular Med       Date:  2016-03-28       Impact factor: 3.843

9.  Executive attention in schizophrenic males and the impact of COMT Val108/158Met genotype on performance on the attention network test.

Authors:  Carolin Opgen-Rhein; Andres H Neuhaus; Carsten Urbanek; Eric Hahn; Thomas Sander; Michael Dettling
Journal:  Schizophr Bull       Date:  2008-01-16       Impact factor: 9.306

10.  A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain.

Authors:  Nicholas J Bray; Paul R Buckland; Nigel M Williams; Hywel J Williams; Nadine Norton; Michael J Owen; Michael C O'Donovan
Journal:  Am J Hum Genet       Date:  2003-06-11       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.